Abstract
Background: Introduction of topical corticosteroids (TC) by Sulzberger and Witten in 1952 led to the emergence of a new therapeutic era in dermatology. But soon the usefulness of these medication became a double-edged sword, owing to their misuse due to easy over the counter availability. The study is aimed at evaluating the range of side effects on the face from misuse of topical steroids.
Aim and Objectives: The primary outcome measures were to find out the most common steroid being used and the reason for its use. Secondary outcome measures were to find the age group and the gender most commonly affected, duration of steroid use, source of these prescriptions, source of procurement and whether the patient is aware of these side effects or not.
Materials and Methods: A total of 322 patients, diagnosed with topical corticosteroid induced face damage attending the outdoor patient department over a period of one year were included in the study. They were examined thoroughly and data obtained was recorded on designed proformas.
Results: Most common steroid being used was Betamethasone vale rate (38.82) mainly for melasma. Most vulnerable age group for TC misuse was between 20 to 39 years and majority (83%) were females. More than half of study group patients (55%) belonged to rural area. Majority were educated population as 34.47% were graduates. In about 64% cases, suggestion for starting TC was given by friends, relatives and neighbors. Steroid induced rosacea (55.59%) was the most common presentation.
Conclusion: The main responsibility for the misuse of topical corticosteroids in our study could be attributed to chemists, the patient himself/herself, friends and family. Apart from this strict implementation of the Government policies is the need of the hour.
Keywords: Rosacea, Dermatitis, Steroids, Acne Vulgaris.
Key Message: Easy availability and rapidity of symptomatic relief that the patient gets in almost any dermatosis remain the root cause behind widespread steroid misuse. Educational and legal approaches need to go hand in hand to curb this rising epidemic of steroid abuse.
References
- Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952; 19:101-2.
- Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol 2014; 59:456-9.
- Lahiri K, Coondoo A. Topical steroid damaged/dependent face (TSDF); An entity of cutaneous pharmaco-dependence. Indian J Dermatol 2016; 61:265-72.
- Thibouto D. Regulation of Human Sebaceous Glands. J Invest Dermatol 2004; 123:1–12.
- Ambika H, Sujatha VC, Yadalla H, Nithya R, Babu AR. Topical corticosteroid abuse on face: A prospective study on outpatients of dermatology. Our Dermatol Online 2014; 5:5-8.
- Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003; 148:493-500.
- Dey VK. Misuse of topical corticosteroids. Indian Dermatol Online J2014;5:436-40.
- Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J Dermatol VenereolLeprol2011; 77:160-6.
- Chohan SN, Suhail M, Salman S, Bajwa UM, Mohummad, Saeed M, Kausar S, Suhail T. Facial abuse of topical steroids and fairness creams: a clinical study of 200 patients. J Pak Assoc Dermatol 2014; 24:204-11.
- Ambika H, Sujatha VC, Yadalla H, Nithya R, Babu AR. Topical corticosteroid abuse on face: A prospective study on outpatients of dermatology. Our Dermatol Online 2014; 5:5-8.
- The Gazette of India. Ministry of Health and Family Welfare (Department of Health and Family Welfare) Notification, New Delhi; 10th March, 2016. Available from: http://www.cdsco.nic.in/writereaddata/GSR705E.pdf.
- Rapaport MJ, Rapaport V. Eyelid dermatitis to red face syndrome to cure: Clinical experience in 100 cases. J Am Acad Dermatol 1999; 41:435-42.
- Lu H, Xiao T, Lu B, Dong D, Yu D, Wei H, et al. Facial corticosteroid addictive dermatitis in Guiyang city, China. Clin Exp Dermatol 2009; 35:618-21.
- Al-Dhalimi MA, Aljawahiri N. Misuse of topical corticosteroids: A clinical study from an Iraqi hospital. East Mediterr Health J 2006; 12:847-52.
- Solomon BA, Glass AT, Rabbin PE. Tinea incognito and "over- the- counter" potent topical steroids. Cutis 1996; 58:295-6.
- Liu ZH, Du XH. Quality of life in patients with steroid dermatitis before and after treatment. J Eur Acad Dermatol Venereol2008; 22:663-9.
- Rathi SK, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: A clinical study of 110 cases. Indian J Dermatol VenereolLeprol2011; 77:42-6.
Corresponding Author
Dr Ghanshyam Verma
Associate Professor, Dept of Dermatology, Venereology, Indira Gandhi Medical College Shimla, HP. India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v7i5.50
